FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2158797321> ?p ?o ?g. }

• W2158797321 endingPage "467" @default.
• W2158797321 startingPage "461" @default.
• W2158797321 abstract "Abstract Purpose: To determine if there is a beneficial effect of amifostine in preventing or reducing the neuropathy induced by high-dose paclitaxel. Methods: Breast cancer patients receiving high-dose infusional paclitaxel (725 mg/m2/24 h) in combination with doxorubicin (165 mg/m2/96 h) and cyclophosphamide (100 mg/kg/2 h; ACT) were studied on two autologous peripheral blood stem cell transplant protocols, one with and one without amifostine (740 mg/m2 administered over 10 min before and 12 h after initiation of the paclitaxel infusion). Patients were evaluated before ACT and 20–40 days later with neurological examination, a composite peripheral neuropathy score, peroneal and sural nerve conduction studies, and quantitative sensory testing. Results: There was no significant difference in paclitaxel maximum concentration, systemic clearance, or area under the curve determinations. Narcotic requirement as well as recovery of hematopoietic counts were also similar in subjects with or without amifostine. After ACT was administered, there was a decrease in peroneal nerve compound muscle action potential amplitude and sural nerve sensory action potential amplitude, as well as an increase in vibratory and cold detection thresholds. Clinical composite peripheral neuropathy scores were similar despite amifostine treatment; and logarithm to the base 2 ratios post/pre ACT showed no significant effect of amifostine on peroneal nerve compound muscle action potential, sural nerve sensory action potential, vibratory detection thresholds, or cold detection thresholds. All subjects had acroparesthesias and lost their ankle deep-tendon reflexes after administration of ACT. Conclusions: Single high-dose paclitaxel produces predictable clinical and neurophysiological changes so that patients receiving high-dose therapy are ideal subjects to test the effectiveness of neuroprotective agents. Amifostine was ineffective in preventing or reducing the neurotoxicity of high-dose paclitaxel." @default.
• W2158797321 created "2016-06-24" @default.
• W2158797321 creator A5002994397 @default.
• W2158797321 creator A5009160607 @default.
• W2158797321 creator A5014173403 @default.
• W2158797321 creator A5023917993 @default.
• W2158797321 creator A5027495771 @default.
• W2158797321 creator A5030731004 @default.
• W2158797321 creator A5039374832 @default.
• W2158797321 creator A5041200743 @default.
• W2158797321 creator A5041550115 @default.
• W2158797321 creator A5064172508 @default.
• W2158797321 creator A5075376684 @default.
• W2158797321 date "2004-01-15" @default.
• W2158797321 modified "2023-09-27" @default.
• W2158797321 title "Neurophysiological Study of Peripheral Neuropathy after High-Dose Paclitaxel" @default.
• W2158797321 cites W1552461420 @default.
• W2158797321 cites W1781345619 @default.
• W2158797321 cites W1981019686 @default.
• W2158797321 cites W1998665709 @default.
• W2158797321 cites W2003237376 @default.
• W2158797321 cites W2006511094 @default.
• W2158797321 cites W2019533472 @default.
• W2158797321 cites W2027414290 @default.
• W2158797321 cites W2029721480 @default.
• W2158797321 cites W2049209075 @default.
• W2158797321 cites W2063912463 @default.
• W2158797321 cites W2079641188 @default.
• W2158797321 cites W2084092457 @default.
• W2158797321 cites W2103751899 @default.
• W2158797321 cites W2111037078 @default.
• W2158797321 cites W2168284025 @default.
• W2158797321 cites W2276767966 @default.
• W2158797321 cites W2333769199 @default.
• W2158797321 cites W99631282 @default.
• W2158797321 doi "https://doi.org/10.1158/1078-0432.ccr-0772-03" @default.
• W2158797321 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14760066" @default.
• W2158797321 hasPublicationYear "2004" @default.
• W2158797321 type Work @default.
• W2158797321 sameAs 2158797321 @default.
• W2158797321 citedByCount "72" @default.
• W2158797321 countsByYear W21587973212012 @default.
• W2158797321 countsByYear W21587973212013 @default.
• W2158797321 countsByYear W21587973212014 @default.
• W2158797321 countsByYear W21587973212015 @default.
• W2158797321 countsByYear W21587973212016 @default.
• W2158797321 countsByYear W21587973212017 @default.
• W2158797321 countsByYear W21587973212018 @default.
• W2158797321 countsByYear W21587973212019 @default.
• W2158797321 countsByYear W21587973212020 @default.
• W2158797321 countsByYear W21587973212021 @default.
• W2158797321 countsByYear W21587973212022 @default.
• W2158797321 countsByYear W21587973212023 @default.
• W2158797321 crossrefType "journal-article" @default.
• W2158797321 hasAuthorship W2158797321A5002994397 @default.
• W2158797321 hasAuthorship W2158797321A5009160607 @default.
• W2158797321 hasAuthorship W2158797321A5014173403 @default.
• W2158797321 hasAuthorship W2158797321A5023917993 @default.
• W2158797321 hasAuthorship W2158797321A5027495771 @default.
• W2158797321 hasAuthorship W2158797321A5030731004 @default.
• W2158797321 hasAuthorship W2158797321A5039374832 @default.
• W2158797321 hasAuthorship W2158797321A5041200743 @default.
• W2158797321 hasAuthorship W2158797321A5041550115 @default.
• W2158797321 hasAuthorship W2158797321A5064172508 @default.
• W2158797321 hasAuthorship W2158797321A5075376684 @default.
• W2158797321 hasConcept C126322002 @default.
• W2158797321 hasConcept C126894567 @default.
• W2158797321 hasConcept C134018914 @default.
• W2158797321 hasConcept C141071460 @default.
• W2158797321 hasConcept C151626666 @default.
• W2158797321 hasConcept C15744967 @default.
• W2158797321 hasConcept C180747234 @default.
• W2158797321 hasConcept C185263204 @default.
• W2158797321 hasConcept C2775907655 @default.
• W2158797321 hasConcept C2776694085 @default.
• W2158797321 hasConcept C2777292972 @default.
• W2158797321 hasConcept C2779387952 @default.
• W2158797321 hasConcept C2779901536 @default.
• W2158797321 hasConcept C2780923182 @default.
• W2158797321 hasConcept C29730261 @default.
• W2158797321 hasConcept C42219234 @default.
• W2158797321 hasConcept C555293320 @default.
• W2158797321 hasConcept C71924100 @default.
• W2158797321 hasConcept C94487597 @default.
• W2158797321 hasConceptScore W2158797321C126322002 @default.
• W2158797321 hasConceptScore W2158797321C126894567 @default.
• W2158797321 hasConceptScore W2158797321C134018914 @default.
• W2158797321 hasConceptScore W2158797321C141071460 @default.
• W2158797321 hasConceptScore W2158797321C151626666 @default.
• W2158797321 hasConceptScore W2158797321C15744967 @default.
• W2158797321 hasConceptScore W2158797321C180747234 @default.
• W2158797321 hasConceptScore W2158797321C185263204 @default.
• W2158797321 hasConceptScore W2158797321C2775907655 @default.
• W2158797321 hasConceptScore W2158797321C2776694085 @default.
• W2158797321 hasConceptScore W2158797321C2777292972 @default.
• W2158797321 hasConceptScore W2158797321C2779387952 @default.
• W2158797321 hasConceptScore W2158797321C2779901536 @default.
• W2158797321 hasConceptScore W2158797321C2780923182 @default.

• next